Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery

NCT: NCT06084091 · RECRUITING

NCT IDNCT06084091
StatusRECRUITING
Start Date2023-10-06
Completion2026-12-31
SponsorSpectrocor (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this observational study is to test in the safety and performance of intraoperative myocardial spectroscopic measurement in open-heart surgery patients The main questions it aims to answer are: * The Devices can record myocardial spectrometric data for analysis, and * How these measures correlate with the occurring events, procedures, and clinical parameters during the operation. * Number of participants with device-related adverse events as assessed by CTCAE v4.0

Frequently Asked Questions

What is Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery?

Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery is a clinical trial registered under NCT06084091. Current status: RECRUITING.

What is the status of NCT06084091?

The current status of NCT06084091 (Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery) is: RECRUITING.

When did Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery start?

Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery started on 2023-10-06.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.